[1,2,4] triazolo [1,5-A] pyridines as kinase inhibitors

Details for Australian Patent Application No. 2011211410 (hide)

Owner Fovea Pharmaceuticals SA

Inventors Leriche, Caroline; Auclair, Eric; Le Roux, Jacques; Middlemiss, David

Agent Freehills

Pub. Number AU-A-2011211410

Filing date 12 August 2011

Wipo publication date 1 September 2011

International Classifications

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 31/437 (2006.01)

A61P 27/02 (2006.01) Drugs for disorders of the senses

Event Publications

25 August 2011 Complete Application Filed

1 September 2011 Application Open to Public Inspection

  Published as AU-A-2011211410

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011211411-Electromagnetic interference shielded panel and method of manufacture

2011211409-Labeled transition metal complexes